Leerink Partnrs Predicts Higher Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Leerink Partnrs raised their Q2 2025 EPS estimates for Henry Schein in a research note issued on Monday, July 14th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $1.22 per share for the quarter, up from their previous forecast of $1.16. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2025 earnings at $1.22 EPS, FY2025 earnings at $4.83 EPS and FY2027 earnings at $5.72 EPS.

HSIC has been the topic of several other reports. Robert W. Baird reaffirmed a “neutral” rating and issued a $72.00 target price (down from $82.00) on shares of Henry Schein in a report on Monday. Leerink Partners set a $75.00 price objective on Henry Schein in a research report on Monday. Wall Street Zen lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Evercore ISI boosted their target price on Henry Schein from $72.00 to $78.00 and gave the company an “in-line” rating in a research report on Wednesday, July 9th. Finally, Baird R W lowered Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday. Eight research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $78.36.

Henry Schein Trading Down 1.9%

Henry Schein stock opened at $69.32 on Wednesday. Henry Schein has a 1 year low of $60.56 and a 1 year high of $82.49. The firm’s 50 day moving average price is $71.79 and its 200-day moving average price is $71.32. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75. The stock has a market cap of $8.44 billion, a P/E ratio of 21.66, a PEG ratio of 2.28 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the firm posted $1.10 EPS. Henry Schein’s quarterly revenue was down .1% compared to the same quarter last year.

Institutional Trading of Henry Schein

Several hedge funds and other institutional investors have recently made changes to their positions in HSIC. Proficio Capital Partners LLC purchased a new stake in Henry Schein during the 4th quarter worth approximately $943,000. HighTower Advisors LLC lifted its stake in shares of Henry Schein by 242.9% during the fourth quarter. HighTower Advisors LLC now owns 43,347 shares of the company’s stock worth $3,000,000 after buying an additional 30,706 shares during the period. Sequoia Financial Advisors LLC grew its holdings in shares of Henry Schein by 7.2% during the fourth quarter. Sequoia Financial Advisors LLC now owns 6,109 shares of the company’s stock valued at $423,000 after buying an additional 412 shares during the last quarter. Thrivent Financial for Lutherans increased its position in shares of Henry Schein by 10.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 116,843 shares of the company’s stock valued at $8,085,000 after acquiring an additional 11,428 shares during the period. Finally, Xponance Inc. raised its stake in Henry Schein by 1.7% in the 4th quarter. Xponance Inc. now owns 19,240 shares of the company’s stock worth $1,331,000 after acquiring an additional 315 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.